Genetic Technologies (GENE) - EPS (earnings per share)

EPS in 2018 (TTM): N/A

In 2007 the company made an earnings per share (EPS) of -5,03 € an increase over its 2006 EPS that were of -16,00 €.

Annual EPS

Year	EPS	Change
2018 (TTM)	N/A
2007	-5,03 €	-68.58%
2006	-16,00 €	35.05%
2005	-11,84 €

EPS for similar companies or competitors

Company	EPS	EPS differencediff.	Country
Eterna Therapeutics ERNA	-5,23 €	N/A	🇺🇸 USA
Myriad Genetics MYGN	-2,82 €	N/A	🇺🇸 USA
LabCorp LH	6,97 €	N/A	🇺🇸 USA
Quest Diagnostics DGX	6,27 €	N/A	🇺🇸 USA
Compugen CGEN	-0,37 €	N/A	🇮🇱 Israel
Danaher DHR	7,43 €	N/A	🇺🇸 USA
Thermo Fisher Scientific TMO	14,22 €	N/A	🇺🇸 USA
Neogen NEOG	-0,11 €	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

EPS history for Genetic Technologies from 2005 to 2018